Bottom line: ‼️ TLGTQ is the post-bankruptcy OTC ticker for Teligent, Inc. The company filed for Chapter 11 in October 2021 and was subsequently delisted from Nasdaq; its common stock now trades on the pink-sheet “Q” market, carrying extremely high risk and, in most restructuring scenarios, little-to-no expected recovery for existing shareholders. Proceed only if you fully accept the probability of a total loss. ⚠️
What’s going on with Teligent (TLGTQ)?
| Key Point |
Detail |
| Chapter 11 filing |
11 Oct 2021, U.S. Bankruptcy Court for the District of Delaware |
| Trading venue |
OTC Pink (Dark/Defunct) under the suffix “Q” to denote bankruptcy |
| Share-count & float |
Frozen at pre-petition levels; any new equity likely reserved for creditors in a reorganization plan |
| Recent quotes |
Sub-penny levels (fractions of a cent), ultra-wide bid/ask spreads, thin volume |
| Likely outcome for equity |
Historical precedents show Ch. 11 equity holders are almost always wiped out unless they inject fresh capital |
Why the ticker is dangerous
- Liquidity Trap
• Market-makers post minimal size; you may not be able to exit without moving the price severely.
- Information Vacuum
• The company halted SEC reporting; there is limited public disclosure after court filings.
- Priority of Claims
• In bankruptcy, secured lenders and trade creditors get paid before common stock. Equity typically receives nothing unless all senior claims are satisfied in full—unlikely here.
- Pump-and-Dump Risk
• Sub-penny bankrupt tickers attract speculative chat-room activity; prices can spike briefly, then collapse as liquidity fades.
What happens next?
• A confirmation hearing for the reorganization plan will determine whether TLGTQ equity is cancelled, converted to a nominal “new equity warrant,” or remains outstanding.
• If no viable plan emerges, liquidation under Chapter 7 is possible, in which case common shares become worthless.
• Court dockets (PACER) and restructuring news services are the only reliable sources for updates.
Practical advice 💡
- Treat any capital committed here as speculative lottery money—not an investment.
- Set limit orders only; never market-order in an illiquid pink-sheet.
- If you hold legacy TLGT shares in a broker account, be prepared for a forced write-off event if the shares are cancelled.
- Consider opportunity cost: even a tiny allocation here could be redeployed into solvent small-cap generics manufacturers with actual turnaround potential (e.g., Lannett, Akorn creditors’ trust).
Need more?
If you’d like:
• A real-time quote chart to see recent micro-price moves 📈
• A breakdown of bankruptcy docket milestones 🔍
• Comparisons with historical Ch. 11 recoveries in the generics sector
just let me know—and I’ll pull the data or documents for you. 😊
7/2/2025 05:55am
